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ABSTRACT
Background: Colon cancer, a colorectal cancer, is the third most common epithelial malignancy in the world. Family history, bloody stool, palpable mass, 
anemia, and abdominal MSCT are symptoms and signs of colon carcinoma. Objective: To determine the relationship between the 5 variables and the 
incidence of colon carcinoma at Dr. Kariadi Hospital, Semarang in 2016.
Methods: a Cross-sectional observational analytical study using medical record (RM) and complementary primary data. The inclusion criteria were 
the complete medical record, and clinical diagnosis of suspected colon carcinoma. Data obtained from the department of Anatomy Pathology/PA (11,794 
PA results) were traced to the medical record section (46 patients with suspected colon carcinoma). The incomplete data were confirmed by: contacting 
the patient/family, obtaining the archive in the laboratory and radiology resulting in 27 patients meeting the inclusion criteria. Analysis was done using 
chi-square test, Spearman-Kendall bivariate correlation, and logistic regression.
Results: Abdominal MSCT was moderately associated with colon carcinoma (p = 0.003; r = 0.488), while family history, bloody stool, palpable mass, and 
anemia were not associated with colon cancer. Analysis between predictors of outcome: Bloody stool was moderately associated with anemia (p = 0.006; r 
= 0.411), and anemia was weakly associated MSCT (p = 0.035; r = 0.351). Abdominal MSCT was the predictive factor for colon carcinoma (p = 0.021). 
Conclusion: Abdominal MSCT was found to be associated with the incidence of colon carcinoma. Bloody stool was associated with anemia, and anemia 
was associated with abdominal MSCT. MSCT was the predictive factor for colon cancer.
Keywords: predictors, diagnosis, family history, bloody stool, palpable mass, anemia, MSCT abdomen, colon carcinoma
colorectal cancer (Tanaka et al., 2010). In Indonesia, 
in 2008, the incidence of  colorectal cancer was 15.6 
per 100,000 female population and 19.1 per 100,000 
male population(World Health Organisation, 2011). In 
Semarang there were 160 cases of  colorectal carcinoma 
in 2010, of  which 35% were aged 51-60 years (Parish 
et al., 2011). The limited funds (including insurance) 
and infrastructure for diagnostic testing in hospitals/
health services in the regions (including rural areas) 
are part of  the reason for the need for a new diagnostic 
method consisting of  a combination of  history, physical 
examination, and minimal supporting examinations 
that can predict colon carcinoma events effectively 
and efficiently.
Determination of  the type of  disease by 
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BACKGROUND
Cancer is one of  the main causes of  morbidity 
and mortality worldwide. In 2012, around 14 million 
new cases and 8.2 million deaths occurred due to cancer 
and are predicted to increase by 22 million cases in 
the next two decades(World Cancer Report, 2015). In 
Indonesia, data from the Ministry of  Health (2007) 
shows that cancer ranked fourth causes of  death from 
non-infectious diseases, after heart attacks, strokes, 
and diabetes mellitus. The increasing incidence of  
cancer is due to the high number of  new cases of  
cancer that come at an advanced stage (Kemenkes RI, 
2015) Colorectal cancer is the third most common 
epithelial malignancy in the world. Every year there are 
around 1,000,000 new cases and 500,000 deaths from 
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determining the diagnosis is absolutely necessary for 
the management of  appropriate treatment. Incorrect 
diagnosis can lead to a series of  errors that can lead 
to the loss of  the patient and family (Sastroasmoro 
and Ismoel, 2014)(Sastroasmoro and Ismoel, 2014). 
Increased access to diagnostic services makes more 
cancer patients can be diagnosed at an early stage 
(Biswas, Ades and Hamilton, 2015). There has been 
a large body of  evidence about the predictive value of  
cancer symptoms from retrospective studies (Esteva et 
al., 2013), but the quality of  recorded data was limited 
(Walter et al., 2016). Thus, in recent years, mortality 
rates due to colonic carcinoma have increased in 
many developing countries (Haggar, Boushey and Ph, 
2009).
After a good history taking and physical 
examination, laboratory examination data and other 
supports can help establish the diagnosis (Simatupang, 
2010). Until now, there have been no studies examining 
a mixture of  various variables consisting of  history, 
physical examination, and investigations to predict 
the incidence of  colon carcinoma. On history taking, 
data from family history and bloody stool were chosen 
because meta-analyzes and systematic reviews showed 
that both have been more predictive as the risk of  
colon carcinoma than complaints of  fatigue, nausea, 
fever, decreased appetite, weight loss, abdominal pain, 
changes in bowel habits, flatulence, peri-anal symptoms 
and tenesmus (Boardman et al., 2007; World Cancer 
Research Fund and American Institute for Cancer 
Research, 2007; Jellema et al., 2010; Etzel et al., 2012; 
Astin et al., 2014; Park et al., 2014; Jensen et al., 2015). 
On physical examination, data from abdominal palpable 
mass was chosen because many studies showed that 
patients with abdominal palpable mass, especially in  a 
large size has a greater likelihood of  colon carcinoma 
(Ang et al., 2008; Sjamsuhidajat R (ed), de Jong (ed), 
Karnadiharjo W (ed), Prasetyono TOH (ed), 2011; 
Vega-Villaamil et al., 2013; Park et al., 2014; Kato et al., 
2016; Renzi et al., 2016). On laboratory investigation, 
the presence of  anemia, was selected as the risk 
factor because many systematic studies and reviews 
suggesting that anemia increases the likelihood of  colon 
carcinoma with  a high specificity and all hospitals can 
do it. (Ludwig et al., 2004; Spivak, Gascon and Ludwig, 
2009; Bekkink et al., 2010; Tettamanti et al., 2010; 
Macciò et al., 2014). On radiological investigations, 
abdominal CT (abdominal MSCT) was selected  as 
risk  factor because  literature, guidelines, systematic 
review and meta-analysis recommended abdominal 
CT for colorectal carcinoma (National Institute for 
Health and Care Excellence (NICE) Guideline, 2014; 
Taylor CR, Lin EC, 2015; Nerad et al., 2016; Teama, 
El-Badry and Yousef, 2016) In addition, CT scan can 
determine tumor location, tumor size, staging of  colon 
cancer before surgery, assessing and staging recurrent 
disease, detecting distant metastases, providing high 
diagnostic accuracy and information about secondary 
tumors, differentiating between benign and malignant 
neoplasms.  In addition, many regional hospitals can 
do it.
New methods capable of  diagnosing colon cancer 
at early stage are needed to reduce mortality due to late 
diagnosis. Before carrying out a new diagnostic test 
on a larger samples, it is necessary to conduct a study 
to find a relationship between family history, bloody 
stool, palpable mass, anemia, and abdominal MSCT 
and the incidence of  colon carcinoma in Dr.Kariadi 
Hospital Semarang in 2016.
METHODS
This type of  research was observational analytical 
study with a cross-sectional design. The samples was 
all cases of  colonic carcinoma in Dr.Kariadi General 
Hospital Semarang in 2016 as many as eligible 46 
patients. The inclusion criteria were complete medical 
record data (RM) with clinical diagnosis of  suspected 
suspect colon carcinoma. Exclusion criteria were site of  
PA biopsy sampling were not in colon (i.e. the intestine, 
ileocaecal, ileum to certain colon, rectosigmoid, 
colorectal, rectum, or anus); undergoing chemotherapy; 
or taking long-term analgesic/steroid drugs.
The consecutive sampling method was used on 
secondary data from RM during 2016, supplemented 
with primary data for validation by contacting the 
patient/family. Data collection was carried out at Dr. 
Kariadi Semarang in July - October 2017.
Data collection was carried out in the Anatomy 
Pathology section followed by recording the identities 
of  all patients whose biopsy samples were sent to 
Pathology Anatomy with suspicion of  colon carcinoma 
(suspect colon carcinoma, colon mass, intra-abdominal 
tumor, ileus obstruction, hematoschezia, hematemesis, 
melena, anemia, fever, or constipation). The number 
of  positive and negative carcinoma cases from the 
data was recorded. Data retrieval continued to the RM 
section looking for patient documents according to the 
identity obtained. Family history data, bloody stool, 
and palpable mass confirmed/verified by contacting 
the family via WhatsApp application (WA)/Short 
Messaging Services (SMS)/telephone whose number 
is written in RM. If  the family cannot be contacted, then 
the data in the RM was used. Anemic data is obtained 
from RM, but if  the RM is unclear, it is verified by 
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acessing the archive at the laboratory installation. CT-
scan data was obtained from RM, if  it is incomplete/
unclear then the data were obtained by searching the 
archive at the radiology installation.
After obtaining validated data from 46 patients, 
there were 27 patients with complete data (Figure 1). 
This research was conducted after ethical clearance 
approval from the Health Research Ethics Commission 
(KEPK) of  the Medical Faculty of  Diponegoro 
University and Dr. Kariadi Hospital Semarang.
STATISTICAL ANALYSIS
To determine the relationship between each 
variable and the incidence of  colon carcinoma and 
the relationship among the variables themselves, 
chi-square analysis was used. All chi-square results 
showing correlation then analyzed for correlation   by 
Spearman-Kendall bivariate correlation analysis to 
determine the strength of  the relationship. To determine 
the variables that have the strongest relationship with 
RESULTS
Patients included in this study were 35 patients 
for family history variables, 45 patients with bloody 
stool, 34 patients with palpable mass, 45 patients for 
anemia, and 37 patients for MSCT abdomen. There 
were 27 patients with the complete data including 
family history, bloody stool, palpable mass, anemia, 
and abdominal MSCT (table 1).
After observing the five variables, it was found 
that the history of  colon carcinoma in families up to 2 
generations above (siblings, parents, siblings of  parents, 
grandparents) was only found in 1 patient with colon 
carcinoma. Blood history in faeces (bloody stool) is 
found in 13 patients with colon carcinoma. The palpable 
abdominal mass was present in 15 patients with colon 
carcinoma. Symptoms of  anemia occur in 29 patients 
with colon carcinoma. The description of  abdominal 
MSCT suggestive of  colon carcinoma was found in 22 
patients with colon carcinoma (Table 2).
  
Figure 1. Consort of Research Results
colon carcinoma, regression analysis was conducted. 
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The results of  chi-square analysis showed that 
there were no significant relationships between 4 
variables (family history, bloody stool, palpable mass, 
and anemia) and colonic carcinoma, p> 0.05. In contrast, 
MSCT and the incidence of  colon carcinoma (p<0.05, 
R = 0.488).
To determine the relationship between variables 
among 5 variables (family history, bloody stool, palpable 
mass, anemia, and abdominal MSCT) in the incidence 
Table 1. Baseline data of Patients with family history, bloody stool, palpable mass, anemia, and abdominal MSCT
Table 2. Relationships between Variables (family history, bloody stool, palpable mass, anemia, and abdominal MSCT) 
with Occurrence of Colonic Carcinoma
*Correlation test with Chi-square, significant only if p<0.05
**Power or correlation with Spearman-Kendall bivariate correlation test, significant only if p<0.05
Tabel 3.  Inter variables correlation (family history, bloody stool, palpable mass, anemia, and abdominal MSCT) on 
Colon Carcinoma Occurence 
there was a moderate relationship between abdominal 
29
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of  colonic carcinoma, chi-square test was performed 
and continued with Spearman-Kendall correlation test 
if  there was a relationship. The results of  the analysis 
showed that bloody stool was moderately associated 
with anemia (p<0.006, R = 0.411). Likewise with 
anemia variables was weakly associated with abdominal 
MSCT (p<0.05, R = 0.351). While the other variables 
did not have a significant relationship (p> 0.05) (Table 
3). 
DISCUSSION
The results of  this study indicate that family 
history factors have no relationship with colonic 
carcinoma. This finding supports a study showing 
that there were no differences in clinical pathological 
characteristics or prognosis of  patients with or without 
a family history of  hepatocellular carcinoma (Huang 
J et al., 2013). In addition, a systematic review of  6 
articles of  prostate cancer stated that a family history of  
prostate cancer does not increase the risk of  progression 
from prostate cancer (Telang et al., 2017). According to 
Haggar and Boushey, the reason for the increased risk is 
still unclear, but may be due to genetic, environmental 
factors or a combination of  both, (Haggar, Boushey 
and Ph, 2009). On the other hand, the study reported 
by Boardman et al showed that patients with a history 
of  colorectal cancer or adenomatous polyps in one or 
more than one of  first-degree relatives (parents, brothers, 
sisters or children (National Cancer Institute, 2016) 
have an increased risk of  malignancy (Boardman et al., 
2007). The risk will be higher in patients with a family 
history of  colorectal cancer or adenomatous polyps at 
any first-degree relatives aged <60 years, or a history 
of  colorectal cancer or adenomatous polyps in 2 or 
more first-degree relatives of  any age (Boardman et 
al., 2007). In this present, due to the small number of  
samples and the family history of  colon carcinoma of  
the Indonesian population is not as many as the other 
country population, there is no relationship between 
family history and colon carcinoma In addition, the 
symptoms/signs of  colon cancer with the identified 
mass in the stomach were found in a small number of  
patients (0.2% of  cases) (Park et al., 2014) causing no 
relationship between family history and the palpable 
mass.
The bloody stool factor was not associated with 
colon carcinoma. This is in line with previous study 
finding showing that suspected source of  bleeding 
originated from 5 mm polyps, hemorrhoids, or right-
sided diverticula, where the study was entirely carried 
out at only one center with a very small sample size 
(range 10-53), and carried out more than 15 years 
ago with the poor quality of  endoscopic imaging in 
colonoscopy(Etzel et al., 2012). Etzel et al study also 
suggested that colon tumors were found in about 1.7% 
of  the melena population (Etzel et al., 2012), which is 
a small number. This is not in line with the research of  
Park et al who stated that in symptomatic right colon 
carcinoma patients there were 20.9% of  blood stool 
symptoms, whereas symptomatic left colon carcinoma 
showed more blood stools at 35.2% (Park et al., 2014). 
Inconsistent results in this study could be due to the 
small number of  samples obtained by researchers as 
in Etzel’s study (Etzel et al., 2012), so the bloody stool 
is not related to colon carcinoma.
The palpable mass factor has no relationship with 
colonic carcinoma. This is in line with the American 
Cancer Society which states that not all masses are 
cancer. The fact is most tumors not cancer (american 
Cancer Society, 2015). Park study found that symptoms/
signs of  colon cancer with the discovery of  abdominal 
mass were very few, which is only 0.2% of  cases (Park et 
al., 2014). This is because small tumors at an early stage 
are not palpable in the abdominal palpation, and the 
tumor is exposed to the condition. Mass in the sigmoid 
is more palpable than mass in other parts of  the colon 
(Sjamsuhidajat R (ed), de Jong (ed), Karnadiharjo W 
(ed), Prasetyono TOH (ed), 2011). This finding is not 
in line with the rest of  the American Cancer Society’s 
claim that the mass that can be cancer can be found to 
feel like a mass during a physical examination (american 
Cancer Society, 2015).
Anemia had no relationship with colon carcinoma. 
This is in line with Maccio et al who stated that anemia 
in oncology patients is often regarded as a side effect of  
cancer therapy (Macciò et al., 2014). There was positive 
correlation between hepcidin and Hb levels, in which 
low hepcidin levels are initially predictive for severe 
anemia (Durigova et al., 2013). The emergence of  iron 
deficiency anemia with anemia in chronic diseases 
together often occurs in the elderly and patients with 
chronic kidney disease (Camaschella and DL, 2015). 
This is not in line with research which states that mild 
anemia is significantly associated with cancer diagnosis 
(Tettamanti et al., 2010). More than 30% of  cancer 
patients have anemia at the time of  diagnosis, where 
the lowest hemoglobin level is found in advanced cancer 
patients (Macciò et al., 2014). Research by Shu et al. 
concluded that anemia in cancer patients, who are 
chronic, has hepcidin levels that are positively correlated 
with IL-6 and in contrast to serum iron (Shu et al., 2015). 
Different results in this study can be caused also because 
the number of  samples obtained is still insufficient, so 
statistically there was no relationship between anemia 
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and carcinoma of  the colon.
Abdominal MSCT factor is associated with colon 
carcinoma and has moderate relationship strength, and 
is a variable that can be used to predict the occurrence of  
colon carcinoma. This is in line with Nerad’s study in the 
form of  a systematic review and meta-analysis that took 
data from 13 CT-scan studies, concluding that CT scans 
have good sensitivity to detect T3-T4 tumors (sensitivity 
90% and specificity 69%), although has low accuracy 
for detecting node involvement (Nerad et al., 2016). 
This study was also supported by studies conducted 
by Taylor et al who stated that CT-scans (including 
multi detector computed tomography (MDCT) and 
CT-colonography can be used as additional screening 
for colon carcinoma, determining tumor location, 
tumor size, as colon cancer staging before surgery, to 
assess and staging recurrent disease, and detect the 
presence of  distant metastases. In addition, CT scans 
can also be used to confirm the diagnosis of  incidental/
accidental colon tumors in suspicion of  other diseases 
(Taylor CR, Lin EC, 2015) because MSCT provides 
high diagnostic accuracy in the detection of  tumors and 
staging to lymph node metastases, and has high reliable 
information on secondary tumors. Moreover, MSCT 
provides advantages in imaging, where intravenous 
contrast enhancement improves the accuracy of  
carcinoma evaluation (Teama, El-Badry and Yousef, 
2016). This is not in line with systematic reviews and a 
meta-analysis of  25 studies on the diagnostic modalities 
of  colorectal cancer metastases to the liver, the results 
were that MRI was superior to CT-scans, where CT 
scans sensitivity 4.8% and its specificity is 95.6%, while 
MRI sensitivity is 81.1% and its specificity is 97.2%, so 
it is still better for MRI than CT-scan (OR = 0.69). It 
was also compared with FDG-PET examination which 
had a successive sensitivity and specificity of  93.8% 
and 98.7% (Floriani et al., 2010). In addition, Kang 
B et al’s study, which results in PET/MRI integrated 
throughout the body, adds value to Contrast-Enhanced 
CT (CECT) in detecting metastatic lesions and unclear 
characterization of  lesions, suggesting that PET / MRI 
can help select appropriate treatment strategies for 
patients with colorectal cancer (Kang et al., 2016).
The bloody stool and anemia factors were 
moderately associated with colon cancer. This is in 
accordance with Arisman’s research stating that iron 
deficiency anemia is generally caused by three things, 
namely chronic blood loss, iron intake and inadequate 
absorption, and increased iron requirements. Chronic 
blood loss for example in malignancy process (Arisman, 
2010). In this case anemia is more closely associated 
with chronic bleeding due to colorectal cancer than as 
a cause of  cancer of  the colon itself. This is supported 
by the results of  statistical analysis that illustrates that 
anemia and abdominal MSCT have low relationship 
strength.The results of  this study indicates that among 
the 5 symptoms and signs of colonic carcinoma variables 
only abdominal MSCT was associated, while other 
variables were not related to colonic carcinoma.
Limitations of  this study include: (1) Age of  
selected patients was not limited, which may affect the 
status of  immunity; (2) the latest intelligence/education 
level of  the patient and the patient’s family, which can 
affect the patient’s/family’s memory history so that 
recall bias can occur; (3) Mortality, whereby to complete 
the data with primary data must contact the family of  
patients who do not necessarily represent the actual 
condition of  the patient, and the patient’s family was 
not willing to collect the data on the deceased patient; 
(4) Medical record data: (a) Many are incomplete, 
where physical and supporting examinations were  not 
always carried out and written in medical  record (only 
taken by patients); (b) Missing contact/no telephone 
number to contact; (c) medical  record  data access was 
limited; (5) Research time was only 1 year (January - 
December 2016); and (6) Location, only conducted in 
one research center.
Referring to these limitations, further research 
needs to increase the number of  samples from several 
hospitals/multicenter with a cohort study design for at 
least 2 years, continuing this study with discriminant 
analysis and as a new diagnostic test with composite 
variables, as well as adding predictor variables such as 
abdominal pain.
CONCLUSION
In general, it can be concluded that there was 
a relationship between abdominal MSCT and colon 
carcinoma, while family history, bloody stool, palpable 
mass, and anemia were not associated with the colonic 
carcinoma. Thus, abdominal MSCT can be suggested 
to be a predictive factor for colon carcinoma.
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